JPMorgan upgrades Nike to overweight, citing a multiyear recovery path
CNBC: Investing
JULY 28, 2025
One of the parts is global inventory and sales growth finally "on track" to alignment by the end of the second quarter in 2026. " The analyst believes Nike's multiyear recovery path is based on several key parts. our FY28 10.0% margin estimate)," he added.
Let's personalize your content